Neutralizing Concentrations of Anti-Botulinum Toxin Antibodies Positively Correlate with Mouse Neutralization Assay Results in a Guinea Pig Model

Botulinum neurotoxins (BoNT) are some of the most toxic proteins known and can induce respiratory failure requiring long-term intensive care. Treatment of botulism includes the administration of antitoxins. Monoclonal antibodies (mAbs) hold considerable promise as BoNT therapeutics and prophylactics...

Full description

Saved in:
Bibliographic Details
Published inToxins Vol. 13; no. 9; p. 671
Main Authors Tomic, Milan T, Farr-Jones, Shauna, Syar, Emily S, Niemuth, Nancy, Kobs, Dean, Hackett, Michael J, Espinoza, Yero, Martinez, Zacchary, Pham, Khanh, Snow, Doris M, Marks, James D, Cobb, Ronald R
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 21.09.2021
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Botulinum neurotoxins (BoNT) are some of the most toxic proteins known and can induce respiratory failure requiring long-term intensive care. Treatment of botulism includes the administration of antitoxins. Monoclonal antibodies (mAbs) hold considerable promise as BoNT therapeutics and prophylactics, due to their potency and safety. A three-mAb combination has been developed that specifically neutralizes BoNT serotype A (BoNT/A), and a separate three mAb combination has been developed that specifically neutralizes BoNT serotype B (BoNT/B). A six mAb cocktail, designated G03-52-01, has been developed that combines the anti-BoNT/A and anti-BoNT/B mAbs. The pharmacokinetics and neutralizing antibody concentration (NAC) of G03-52-01 has been determined in guinea pigs, and these parameters were correlated with protection against an inhalation challenge of BoNT/A1 or BoNT/B1. Previously, it was shown that each antibody demonstrated a dose-dependent mAb serum concentration and reached maximum circulating concentrations within 48 h after intramuscular (IM) or intraperitoneal (IP) injection and that a single IM injection of G03-52-01 administered 48 h pre-exposure protected guinea pigs against an inhalation challenge of up to 93 LD s of BoNT/A1 and 116 LD s of BoNT/B1. The data presented here advance our understanding of the relationship of the neutralizing NAC to the measured circulating antibody concentration and provide additional support that a single IM or intravenous (IV) administration of G03-52-01 will provide pre-exposure prophylaxis against botulism from an aerosol exposure of BoNT/A and BoNT/B.
AbstractList Botulinum neurotoxins (BoNT) are some of the most toxic proteins known and can induce respiratory failure requiring long-term intensive care. Treatment of botulism includes the administration of antitoxins. Monoclonal antibodies (mAbs) hold considerable promise as BoNT therapeutics and prophylactics, due to their potency and safety. A three-mAb combination has been developed that specifically neutralizes BoNT serotype A (BoNT/A), and a separate three mAb combination has been developed that specifically neutralizes BoNT serotype B (BoNT/B). A six mAb cocktail, designated G03-52-01, has been developed that combines the anti-BoNT/A and anti-BoNT/B mAbs. The pharmacokinetics and neutralizing antibody concentration (NAC) of G03-52-01 has been determined in guinea pigs, and these parameters were correlated with protection against an inhalation challenge of BoNT/A1 or BoNT/B1. Previously, it was shown that each antibody demonstrated a dose-dependent mAb serum concentration and reached maximum circulating concentrations within 48 h after intramuscular (IM) or intraperitoneal (IP) injection and that a single IM injection of G03-52-01 administered 48 h pre-exposure protected guinea pigs against an inhalation challenge of up to 93 LD 50 s of BoNT/A1 and 116 LD 50 s of BoNT/B1. The data presented here advance our understanding of the relationship of the neutralizing NAC to the measured circulating antibody concentration and provide additional support that a single IM or intravenous (IV) administration of G03-52-01 will provide pre-exposure prophylaxis against botulism from an aerosol exposure of BoNT/A and BoNT/B.
Botulinum neurotoxins (BoNT) are some of the most toxic proteins known and can induce respiratory failure requiring long-term intensive care. Treatment of botulism includes the administration of antitoxins. Monoclonal antibodies (mAbs) hold considerable promise as BoNT therapeutics and prophylactics, due to their potency and safety. A three-mAb combination has been developed that specifically neutralizes BoNT serotype A (BoNT/A), and a separate three mAb combination has been developed that specifically neutralizes BoNT serotype B (BoNT/B). A six mAb cocktail, designated G03-52-01, has been developed that combines the anti-BoNT/A and anti-BoNT/B mAbs. The pharmacokinetics and neutralizing antibody concentration (NAC) of G03-52-01 has been determined in guinea pigs, and these parameters were correlated with protection against an inhalation challenge of BoNT/A1 or BoNT/B1. Previously, it was shown that each antibody demonstrated a dose-dependent mAb serum concentration and reached maximum circulating concentrations within 48 h after intramuscular (IM) or intraperitoneal (IP) injection and that a single IM injection of G03-52-01 administered 48 h pre-exposure protected guinea pigs against an inhalation challenge of up to 93 LD50s of BoNT/A1 and 116 LD50s of BoNT/B1. The data presented here advance our understanding of the relationship of the neutralizing NAC to the measured circulating antibody concentration and provide additional support that a single IM or intravenous (IV) administration of G03-52-01 will provide pre-exposure prophylaxis against botulism from an aerosol exposure of BoNT/A and BoNT/B.
Botulinum neurotoxins (BoNT) are some of the most toxic proteins known and can induce respiratory failure requiring long-term intensive care. Treatment of botulism includes the administration of antitoxins. Monoclonal antibodies (mAbs) hold considerable promise as BoNT therapeutics and prophylactics, due to their potency and safety. A three-mAb combination has been developed that specifically neutralizes BoNT serotype A (BoNT/A), and a separate three mAb combination has been developed that specifically neutralizes BoNT serotype B (BoNT/B). A six mAb cocktail, designated G03-52-01, has been developed that combines the anti-BoNT/A and anti-BoNT/B mAbs. The pharmacokinetics and neutralizing antibody concentration (NAC) of G03-52-01 has been determined in guinea pigs, and these parameters were correlated with protection against an inhalation challenge of BoNT/A1 or BoNT/B1. Previously, it was shown that each antibody demonstrated a dose-dependent mAb serum concentration and reached maximum circulating concentrations within 48 h after intramuscular (IM) or intraperitoneal (IP) injection and that a single IM injection of G03-52-01 administered 48 h pre-exposure protected guinea pigs against an inhalation challenge of up to 93 LD s of BoNT/A1 and 116 LD s of BoNT/B1. The data presented here advance our understanding of the relationship of the neutralizing NAC to the measured circulating antibody concentration and provide additional support that a single IM or intravenous (IV) administration of G03-52-01 will provide pre-exposure prophylaxis against botulism from an aerosol exposure of BoNT/A and BoNT/B.
Author Tomic, Milan T
Cobb, Ronald R
Martinez, Zacchary
Snow, Doris M
Marks, James D
Syar, Emily S
Farr-Jones, Shauna
Pham, Khanh
Niemuth, Nancy
Espinoza, Yero
Kobs, Dean
Hackett, Michael J
AuthorAffiliation 3 Battelle Biomedical Research Center, West Jefferson, Columbus, OH 43162, USA; syare@battelle.org (E.S.S.); niemuth@battelle.org (N.N.); dkobs@amplify-bio.com (D.K.); mike.hackett@gmail.com (M.J.H.)
1 National Resilience, Inc., 2061 Challenger Dr., Alameda, CA 94501, USA; yero.espinoza@resilience.com (Y.E.); zacchary.martinez@resilience.com (Z.M.); Khanh.pham@alector.com (K.P.)
2 Department of Anesthesia and Perioperative Care, University of California, 1001 Potrero Ave., San Francisco, CA 94110, USA; shauna.farr-jones@ucsf.edu (S.F.-J.); jim.marks@ucsf.edu (J.D.M.)
4 National Resilience, Inc., 13200 NW, Nano Ct, Alachua, FL 32615, USA; doris.snow@resilience.com (D.M.S.); RonCobb76@yahoo.com (R.R.C.)
AuthorAffiliation_xml – name: 2 Department of Anesthesia and Perioperative Care, University of California, 1001 Potrero Ave., San Francisco, CA 94110, USA; shauna.farr-jones@ucsf.edu (S.F.-J.); jim.marks@ucsf.edu (J.D.M.)
– name: 3 Battelle Biomedical Research Center, West Jefferson, Columbus, OH 43162, USA; syare@battelle.org (E.S.S.); niemuth@battelle.org (N.N.); dkobs@amplify-bio.com (D.K.); mike.hackett@gmail.com (M.J.H.)
– name: 1 National Resilience, Inc., 2061 Challenger Dr., Alameda, CA 94501, USA; yero.espinoza@resilience.com (Y.E.); zacchary.martinez@resilience.com (Z.M.); Khanh.pham@alector.com (K.P.)
– name: 4 National Resilience, Inc., 13200 NW, Nano Ct, Alachua, FL 32615, USA; doris.snow@resilience.com (D.M.S.); RonCobb76@yahoo.com (R.R.C.)
Author_xml – sequence: 1
  givenname: Milan T
  surname: Tomic
  fullname: Tomic, Milan T
  organization: National Resilience, Inc., 2061 Challenger Dr., Alameda, CA 94501, USA
– sequence: 2
  givenname: Shauna
  orcidid: 0000-0003-4130-6332
  surname: Farr-Jones
  fullname: Farr-Jones, Shauna
  organization: Department of Anesthesia and Perioperative Care, University of California, 1001 Potrero Ave., San Francisco, CA 94110, USA
– sequence: 3
  givenname: Emily S
  surname: Syar
  fullname: Syar, Emily S
  organization: Battelle Biomedical Research Center, West Jefferson, Columbus, OH 43162, USA
– sequence: 4
  givenname: Nancy
  surname: Niemuth
  fullname: Niemuth, Nancy
  organization: Battelle Biomedical Research Center, West Jefferson, Columbus, OH 43162, USA
– sequence: 5
  givenname: Dean
  surname: Kobs
  fullname: Kobs, Dean
  organization: Battelle Biomedical Research Center, West Jefferson, Columbus, OH 43162, USA
– sequence: 6
  givenname: Michael J
  surname: Hackett
  fullname: Hackett, Michael J
  organization: Battelle Biomedical Research Center, West Jefferson, Columbus, OH 43162, USA
– sequence: 7
  givenname: Yero
  surname: Espinoza
  fullname: Espinoza, Yero
  organization: National Resilience, Inc., 2061 Challenger Dr., Alameda, CA 94501, USA
– sequence: 8
  givenname: Zacchary
  surname: Martinez
  fullname: Martinez, Zacchary
  organization: National Resilience, Inc., 2061 Challenger Dr., Alameda, CA 94501, USA
– sequence: 9
  givenname: Khanh
  surname: Pham
  fullname: Pham, Khanh
  organization: National Resilience, Inc., 2061 Challenger Dr., Alameda, CA 94501, USA
– sequence: 10
  givenname: Doris M
  surname: Snow
  fullname: Snow, Doris M
  organization: National Resilience, Inc., 13200 NW, Nano Ct, Alachua, FL 32615, USA
– sequence: 11
  givenname: James D
  orcidid: 0000-0003-0562-3517
  surname: Marks
  fullname: Marks, James D
  organization: Department of Anesthesia and Perioperative Care, University of California, 1001 Potrero Ave., San Francisco, CA 94110, USA
– sequence: 12
  givenname: Ronald R
  surname: Cobb
  fullname: Cobb, Ronald R
  organization: National Resilience, Inc., 13200 NW, Nano Ct, Alachua, FL 32615, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34564675$$D View this record in MEDLINE/PubMed
BookMark eNpdkk9vVCEUxV9Mja21W5eGxI2bqfAef4aNyTjR2qRqY-qa8OC-KRMGKvCq47fwG8vM1ElHNsDlnB9wcp83RyEGaJqXBJ93ncRvS_zlQiYdlpgL8qQ5abFoJ5wzcvRofdyc5bzEdXQdkUQ8a447yjjlgp00f77AWJL27rcLCzSPwUCo--JiyCgOaBaKm7yPZfQujCt0s7lxW-yjdZDRdcyuuHvw62pOCbwugH66cos-xzED2uO3SDTLWa_RN8ijLxlVlEYXowug0bVbVIsF_6J5Omif4exhPm2-f_xwM_80ufp6cTmfXU0MndIysXyqSW8IWLCdxVxP6SAFpdRqbDFhllAhCZcdsS2jBqzgLWg2aMoso4R2p83ljmujXqq75FY6rVXUTm0LMS2UTsUZD0oPhg9SC22q0UyxNAC47UknqYWeiMp6t2Pdjf0K7C5DfwA9PAnuVi3ivZpSQRjbAN48AFL8MUIuauWyAe91gJqjapngEgvBZJW-_k-6jGMKNaqtiuEWM1ZV5zuVSTHnBMP-MQSrTfOow-aphlePv7CX_2uV7i9PqsZE
CitedBy_id crossref_primary_10_3390_toxins15090563
crossref_primary_10_1007_s00204_022_03271_9
crossref_primary_10_1007_s00253_023_12515_2
crossref_primary_10_1016_j_chemosphere_2022_134358
crossref_primary_10_1007_s11274_024_03990_4
crossref_primary_10_35825_2587_5728_2023_7_3_261_275
Cites_doi 10.3390/toxins11040208
10.1111/j.1699-0463.1960.tb04741.x
10.1006/jmbi.1999.2945
10.1007/978-1-4757-9542-4_52
10.3201/eid0808.010516
10.1093/cid/cix816
10.2807/ese.16.49.20034-en
10.1016/j.vaccine.2018.02.042
10.1016/j.ab.2011.09.030
10.1128/AAC.02830-14
10.1128/CMR.3.1.66
10.1128/AAC.02329-20
10.3390/toxins11060345
10.1128/mr.46.1.86-94.1982
10.1073/pnas.172229899
10.3390/toxins7093405
10.1128/AAC.01270-19
10.1093/clinids/23.2.337
10.1056/NEJM199104253241707
10.1371/journal.pone.0222670
10.1002/(SICI)1099-1263(199912)19:1+3.0.CO;2-9
10.2807/ese.16.49.20035-en
10.1093/infdis/jiv327
10.1371/journal.pone.0174187
10.1001/jama.285.8.1059
10.1371/journal.pone.0209019
10.3390/toxins10030105
10.7326/0003-4819-129-3-199808010-00011
10.1212/01.wnl.0000187127.92446.4c
10.1016/j.ab.2012.08.005
10.1002/mds.20023
10.1086/444507
10.1371/journal.pone.0101638
10.1093/infdis/jit449
10.1056/NEJMoa051926
10.3390/toxins9100309
10.3390/toxins13010031
10.1097/DMP.0b013e318158c5fd
10.1016/S0140-6736(05)72119-X
10.1371/journal.pone.0186892
ContentType Journal Article
Copyright 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021 by the authors. 2021
Copyright_xml – notice: 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021 by the authors. 2021
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7T7
7U7
7X7
7XB
88E
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
ATCPS
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
P64
PATMY
PIMPY
PQEST
PQQKQ
PQUKI
PYCSY
7X8
5PM
DOA
DOI 10.3390/toxins13090671
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Toxicology Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Biological Science Database
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
Environmental Science Collection
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Student
Technology Research Database
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Agricultural & Environmental Science Collection
Biological Science Collection
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
Toxicology Abstracts
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Environmental Science Database
Engineering Research Database
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database
MEDLINE

CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 2072-6651
ExternalDocumentID oai_doaj_org_article_afc6f9a7ac414c809cee02b1394deb17
10_3390_toxins13090671
34564675
Genre Research Support, U.S. Gov't, Non-P.H.S
Journal Article
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GroupedDBID ---
2XV
3V.
53G
5VS
7X7
7XC
88E
8FE
8FH
8FI
8FJ
A8Z
AADQD
AAHBH
ABDBF
ABUWG
ACGFO
ACPRK
ADBBV
AEGXH
AENEX
AFKRA
AFRAH
AFZYC
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CGR
CUY
CVF
DIK
E3Z
EBD
ECM
EIF
EMOBN
ESTFP
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IHR
KQ8
LK8
M1P
M48
M7P
MODMG
M~E
NPM
OK1
PATMY
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
PYCSY
RIG
RNS
RPM
SV3
TR2
TUS
UKHRP
AAYXX
CITATION
7T7
7U7
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
K9.
P64
PQEST
PQUKI
7X8
5PM
ID FETCH-LOGICAL-c484t-d68a1bc1eded3d06a84f97444da0d015d147916931d254ced762ea5fa45d54143
IEDL.DBID RPM
ISSN 2072-6651
IngestDate Tue Oct 22 15:15:10 EDT 2024
Tue Sep 17 20:40:49 EDT 2024
Wed Dec 04 14:03:40 EST 2024
Sat Nov 09 09:34:03 EST 2024
Fri Dec 06 09:04:01 EST 2024
Sat Sep 28 08:21:51 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords guinea pig inhalation model
botulism
botulinum neurotoxin
monoclonal antibody (mAb)
mouse neutralization assay (MNA)
oligoclonal antibody
aerosol
neutralizing antibody concentration (NAC)
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c484t-d68a1bc1eded3d06a84f97444da0d015d147916931d254ced762ea5fa45d54143
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-0562-3517
0000-0003-4130-6332
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471557/
PMID 34564675
PQID 2576502055
PQPubID 2032321
ParticipantIDs doaj_primary_oai_doaj_org_article_afc6f9a7ac414c809cee02b1394deb17
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8471557
proquest_miscellaneous_2576907759
proquest_journals_2576502055
crossref_primary_10_3390_toxins13090671
pubmed_primary_34564675
PublicationCentury 2000
PublicationDate 20210921
PublicationDateYYYYMMDD 2021-09-21
PublicationDate_xml – month: 9
  year: 2021
  text: 20210921
  day: 21
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Toxins
PublicationTitleAlternate Toxins (Basel)
PublicationYear 2021
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Nayak (ref_27) 2014; 58
Barash (ref_10) 2014; 209
Arnon (ref_13) 2001; 285
ref_36
ref_35
Maslanka (ref_11) 2016; 213
ref_33
ref_32
Meng (ref_25) 2012; 421
ref_30
Guptill (ref_28) 2021; 65
Fan (ref_18) 2015; 7
Arnon (ref_38) 2006; 354
Lacy (ref_7) 1999; 291
Casadevall (ref_23) 2002; 8
Yu (ref_41) 2017; 66
ref_19
ref_39
Khouri (ref_16) 2018; 36
ref_37
Hatheway (ref_8) 1990; 3
Jankovic (ref_47) 1994; Volume 25
Pingeon (ref_4) 2011; 16
Shapiro (ref_34) 1998; 129
Sobel (ref_15) 2005; 41
Marks (ref_21) 2004; 19
Schechter (ref_6) 2000; 355
Dembek (ref_14) 2007; 1
Meng (ref_24) 2012; 430
Jankovic (ref_40) 1991; 324
Moller (ref_12) 1960; 48
ref_46
ref_45
ref_22
ref_44
ref_43
ref_20
ref_42
Snow (ref_29) 2019; 63
Hibbs (ref_2) 1996; 23
Gill (ref_5) 1982; 46
ref_26
ref_9
Gupta (ref_1) 2005; 65
Gelzleichter (ref_31) 1999; 19
Jalava (ref_3) 2011; 16
Nowakowski (ref_17) 2002; 99
References_xml – ident: ref_9
– ident: ref_26
  doi: 10.3390/toxins11040208
– volume: 48
  start-page: 80
  year: 1960
  ident: ref_12
  article-title: Preliminary report on the isolation of an apparently new type of CI. botulinum
  publication-title: Acta Pathol. Microbiol. Scand.
  doi: 10.1111/j.1699-0463.1960.tb04741.x
  contributor:
    fullname: Moller
– ident: ref_32
– volume: 291
  start-page: 1091
  year: 1999
  ident: ref_7
  article-title: Sequence homology and structural analysis of the clostridial neurotoxins
  publication-title: J. Mol. Biol.
  doi: 10.1006/jmbi.1999.2945
  contributor:
    fullname: Lacy
– ident: ref_30
  doi: 10.1007/978-1-4757-9542-4_52
– volume: 8
  start-page: 833
  year: 2002
  ident: ref_23
  article-title: Passive antibody administration (immediate immunity) as a specific defense against biological weapons
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid0808.010516
  contributor:
    fullname: Casadevall
– volume: 66
  start-page: S57
  year: 2017
  ident: ref_41
  article-title: Safety and Improved Clinical Outcomes in Patients Treated With New Equine-Derived Heptavalent Botulinum Antitoxin
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/cix816
  contributor:
    fullname: Yu
– volume: 16
  start-page: 20034
  year: 2011
  ident: ref_3
  article-title: Two cases of food-borne botulism in Finland caused by conserved olives, October 2011
  publication-title: Eurosurveillance
  doi: 10.2807/ese.16.49.20034-en
  contributor:
    fullname: Jalava
– volume: 36
  start-page: 2041
  year: 2018
  ident: ref_16
  article-title: Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with pre-existing botulinum toxoid immunity
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2018.02.042
  contributor:
    fullname: Khouri
– ident: ref_39
– volume: 421
  start-page: 351
  year: 2012
  ident: ref_25
  article-title: Domain-based assays of individual antibody concentrations in an oligoclonal combination targeting a single protein
  publication-title: Anal. Biochem.
  doi: 10.1016/j.ab.2011.09.030
  contributor:
    fullname: Meng
– volume: Volume 25
  start-page: 93
  year: 1994
  ident: ref_47
  article-title: Immunogenicity of the neurotoxins of Clostridium botulinum
  publication-title: Therapy with Botulinum Toxin
  contributor:
    fullname: Jankovic
– volume: 58
  start-page: 5047
  year: 2014
  ident: ref_27
  article-title: Safety and pharmacokinetics of XOMA 3AB, a novel mixture of three monoclonal antibodies against botulinum toxin A
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.02830-14
  contributor:
    fullname: Nayak
– volume: 3
  start-page: 66
  year: 1990
  ident: ref_8
  article-title: Toxigenic clostridia
  publication-title: Clin. Microbiol. Rev.
  doi: 10.1128/CMR.3.1.66
  contributor:
    fullname: Hatheway
– volume: 65
  start-page: e0232920
  year: 2021
  ident: ref_28
  article-title: Safety, Tolerability and Pharmacokinetics of NTM-1632, a Novel Mixture of Three Monoclonal Antibodies against Botulinum Toxin B
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.02329-20
  contributor:
    fullname: Guptill
– ident: ref_42
– ident: ref_43
  doi: 10.3390/toxins11060345
– volume: 46
  start-page: 86
  year: 1982
  ident: ref_5
  article-title: Bacterial toxins: A table of lethal amounts
  publication-title: Microbiol. Rev.
  doi: 10.1128/mr.46.1.86-94.1982
  contributor:
    fullname: Gill
– volume: 99
  start-page: 11346
  year: 2002
  ident: ref_17
  article-title: Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.172229899
  contributor:
    fullname: Nowakowski
– volume: 7
  start-page: 3405
  year: 2015
  ident: ref_18
  article-title: Monoclonal antibodies that inhibit the proteolytic activity of botulinum neurotoxin serotype/B
  publication-title: Toxins
  doi: 10.3390/toxins7093405
  contributor:
    fullname: Fan
– volume: 63
  start-page: e01270-19
  year: 2019
  ident: ref_29
  article-title: Safety and Pharmacokinetics of a Four Monoclonal Antibody Combination Against Botulinum C and D Neurotoxins
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.01270-19
  contributor:
    fullname: Snow
– volume: 23
  start-page: 337
  year: 1996
  ident: ref_2
  article-title: Experience with the use of an investigational F(ab’)2 heptavalent botulism immune globulin of equine origin during an outbreak of type E botulism in Egypt
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/clinids/23.2.337
  contributor:
    fullname: Hibbs
– volume: 324
  start-page: 1186
  year: 1991
  ident: ref_40
  article-title: Therapeutic uses of botulinum toxin
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM199104253241707
  contributor:
    fullname: Jankovic
– ident: ref_35
  doi: 10.1371/journal.pone.0222670
– volume: 19
  start-page: S35
  year: 1999
  ident: ref_31
  article-title: Protection against botulinum toxins provided by passive immunization with botulinum human immune globulin: Evaluation using an inhalation model
  publication-title: J. Appl. Toxicol.
  doi: 10.1002/(SICI)1099-1263(199912)19:1+3.0.CO;2-9
  contributor:
    fullname: Gelzleichter
– volume: 16
  start-page: 20035
  year: 2011
  ident: ref_4
  article-title: Two outbreaks of botulism associated with consumption of green olive paste, France, September 2011
  publication-title: Eurosurveillance
  doi: 10.2807/ese.16.49.20035-en
  contributor:
    fullname: Pingeon
– volume: 213
  start-page: 379
  year: 2016
  ident: ref_11
  article-title: A novel botulinum neurotoxin, previously reported as serotype H, has a hybrid-like structure with regions of similarity to the structures of serotypes A and F and is neutralized with serotype A antitoxin
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jiv327
  contributor:
    fullname: Maslanka
– ident: ref_20
  doi: 10.1371/journal.pone.0174187
– volume: 285
  start-page: 1059
  year: 2001
  ident: ref_13
  article-title: Botulinum toxin as a biological weapon: Medical and public health management
  publication-title: JAMA
  doi: 10.1001/jama.285.8.1059
  contributor:
    fullname: Arnon
– ident: ref_36
  doi: 10.1371/journal.pone.0209019
– ident: ref_19
  doi: 10.3390/toxins10030105
– volume: 129
  start-page: 221
  year: 1998
  ident: ref_34
  article-title: Botulism in the United States: A clinical and epidemiologic review
  publication-title: Ann. Intern. Med.
  doi: 10.7326/0003-4819-129-3-199808010-00011
  contributor:
    fullname: Shapiro
– volume: 65
  start-page: 1694
  year: 2005
  ident: ref_1
  article-title: Adult botulism type F in the United States, 1981–2002
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000187127.92446.4c
  contributor:
    fullname: Gupta
– volume: 430
  start-page: 141
  year: 2012
  ident: ref_24
  article-title: Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein
  publication-title: Anal. Biochem.
  doi: 10.1016/j.ab.2012.08.005
  contributor:
    fullname: Meng
– ident: ref_46
– volume: 19
  start-page: S101
  year: 2004
  ident: ref_21
  article-title: Deciphering antibody properties that lead to potent botulinum neurotoxin neutralization
  publication-title: Mov. Disord. Off. J. Mov. Disord. Soc.
  doi: 10.1002/mds.20023
  contributor:
    fullname: Marks
– volume: 41
  start-page: 1167
  year: 2005
  ident: ref_15
  article-title: Botulism
  publication-title: Clin. Infect. Dis.
  doi: 10.1086/444507
  contributor:
    fullname: Sobel
– ident: ref_33
  doi: 10.1371/journal.pone.0101638
– volume: 209
  start-page: 183
  year: 2014
  ident: ref_10
  article-title: A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jit449
  contributor:
    fullname: Barash
– volume: 354
  start-page: 462
  year: 2006
  ident: ref_38
  article-title: Human Botulism Immune Globulin for the Treatment of Infant Botulism
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa051926
  contributor:
    fullname: Arnon
– ident: ref_22
  doi: 10.3390/toxins9100309
– ident: ref_44
  doi: 10.3390/toxins13010031
– ident: ref_45
– volume: 1
  start-page: 122
  year: 2007
  ident: ref_14
  article-title: Botulism: Cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities
  publication-title: Disaster Med. Public Health Prep.
  doi: 10.1097/DMP.0b013e318158c5fd
  contributor:
    fullname: Dembek
– volume: 355
  start-page: 237
  year: 2000
  ident: ref_6
  article-title: Extreme potency of botulinum toxin
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)72119-X
  contributor:
    fullname: Schechter
– ident: ref_37
  doi: 10.1371/journal.pone.0186892
SSID ssj0000331917
Score 2.3467624
Snippet Botulinum neurotoxins (BoNT) are some of the most toxic proteins known and can induce respiratory failure requiring long-term intensive care. Treatment of...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 671
SubjectTerms aerosol
Animals
Antibodies
Antibodies, Monoclonal - immunology
Antibodies, Monoclonal - therapeutic use
Antibodies, Neutralizing - immunology
Antibodies, Neutralizing - therapeutic use
Antitoxins
Antitoxins - immunology
Antitoxins - therapeutic use
botulinum neurotoxin
Botulinum toxin
Botulinum toxin type A
Botulinum toxin type B
Botulinum Toxins - toxicity
Botulism
Botulism - drug therapy
Clostridium botulinum - genetics
Disease Models, Animal
Drug Combinations
Estimates
Exposure
Food contamination
guinea pig inhalation model
Guinea Pigs
Inhalation
Injection
Intravenous administration
Mice
Monoclonal antibodies
monoclonal antibody (mAb)
Neurotoxins
Neutralization
Neutralizing
oligoclonal antibody
Pharmacokinetics
Prophylaxis
Respiration
Respiratory failure
Serogroup
Swine
Toxins
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fa9UwFA6yJ19EN39UpxxB9KmsaZOmfbwbbkPYGLLB3kqapHrhLpW1HV7_C_9jz0m7y60MfPE1TUPac3LyfcnJF8Y-4IgRTro0TnmTxLS1Fmshk5jXIrM1Eue8oXXIs_P89Ep8uZbXW1d9UU7YKA88_rgD3Zi8KbXSRnBhiqTEqJ6kNQIXYTHOjOfIk3SLTIUYnGVEREaVxgx5_UHf_lz6DiN2ifGZz2ahINb_EML8O1Fya-Y5fsqeTJARFmNXn7FHzu-yvYVHunyzho8QkjjD6vge-33uhrB28QunJDiiM4l-EsbtoG1g4ftlfNj2lH8-3MAldTcU1i2lE8JFyOG6c6s1vnwbDro4oLVaOGuHzsGm-dAkoHH1Gr66blj1HWBTGk4GxK0aLpbfgO5ZWz1nV8efL49O4-nWhdiIQvSxzQvNa8OddTazSa4L0SDpEMLqxCJ4sFyokiRcuEVyaZzFcOq0bNDElu4Uz16wHd9694oBoqvMSqVUaVLRGFUWwqYFIgKtaqNzEbFP91aofoziGhWSErJXNbdXxA7JSJtaJIodCtBVqslVqn-5SsT2701cTSO1q4hwScTMUkbs_eYxjjHaONHe4c8NdUrSCiwj9nL0iE1PMtLjQdYVMTXzlVlX50_88nvQ8SZgIKV6_T--7Q17nFK2De2X8X22098O7i3Cpb5-F0bGH1auGSQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwELWgXLggoHwECjISgpPVOLHj5IS2FaVCalWhVtpb5NhOWWnrtJsEdfsv-MfMeLOBIMQ1TqxRZjx-Mx6_IeQ9rBjhpEtYwuuY4dEa00LGjFcitRUEzlmNeciT0-z4Qnydy_mQcGuHssqtTwyO2jYGc-T7CIwlYBspP13fMOwahaerQwuN--QBhyG0cDVXY44lTlMMRzZcjSlE9_tdc7vwLfjtArw0n-xFgbL_Xzjz73LJP_afo8fk0QAc6Wyj6SfknvNPye7MQ9B8taYfaCjlDDnyXfLz1PUhg3EHGxM9xJuJfqDHbWlT05nvFuyg6bAKvb-i5yhueFg1WFRIz0Il1w-3XMPHq3DdxVHM2NKTpm8dHacPU1JQsV7Tb67tl11LYSpNv_SAXjU9W1xS7La2fEYujj6fHx6zofcCMyIXHbNZrnlluLPOpjbOdC5qCD2EsDq2ACEsF6pAIhduIcQ0zoJTdVrWoGiLncXT52THN969JBQwVmqlUqowiaiNKnJhkxxwgVaV0ZmIyMetFsrrDcVGCaEJ6quc6isiB6ik8S2kxg4PmtVlOay0UtcmqwuttAExTB4XAAPipAKkKyxsTCoie1sVl8N6bcvf1hWRd-MwrDQ8PtHewc8N7xTIGFhE5MXGIkZJUmTlgdgrImpiKxNRpyN-8T2weSM8kFK9-r9Yr8nDBKtp8DyM75GdbtW7NwCHuuptsPlfXhAPbA
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB2hIqFeEFA-QgsyEoJTIB92nBwQ2laUCmmrCnWl3iLHdtqVtg5skqrLv-AfM-PNLl20J65JbFmZGc979vgZ4C1GDLfCJmES11FIW2uh4iIK44qnpkLinNW0Djk-zU4m_NuFuPhb_zT8wHYrtaP7pCbz2Yfbn4vPGPCfiHEiZf_YNbdT1-JkXODUi0zofoJZkcq7xgPU97NymhI1Weo2bmm2Cw9SklbJqOLwTorySv7b4Oe_VZR30tLxI3g44Ek2WjrAY7hn3RPYGznk0tcL9o75Ck-_dL4Hv09t7xc2fmG-Ykd0YNENqrkta2o2ct00PGw6Kk7vr9k5jdw_rBqqNWRnvsDrxs4W2HjuT8FYRgu5bNz0rWXr7n2XDC2vFuy7bftZ1zLsSrGvPYJaxc6ml4wuYZs9hcnxl_Ojk3C4kiHUPOddaLJcxZWOrbEmNVGmcl4jI-HcqMggsjAxlwXpu8QGmae2Budaq0SN9jd04Xj6DHZc4-wLYAi9UiOklIVOeK1lkXOT5AgXlKy0yngA71dWKH8slTdKZCxkunLTdAEckpHWX5Fitn_QzC_LIQBLVeusLpRUGoeh86hAdBAlFQJgbjBfyQAOViYuV15YEhsTCKiFCODN-jUGIO2qKGfx5_pvChISLAJ4vvSI9UhWHhWA3PCVjaFuvnHTKy_yTahBCPnyv1vuw25C9Te0gxYfwE437-0rBFBd9dpHxh9R4SB9
  priority: 102
  providerName: Scholars Portal
Title Neutralizing Concentrations of Anti-Botulinum Toxin Antibodies Positively Correlate with Mouse Neutralization Assay Results in a Guinea Pig Model
URI https://www.ncbi.nlm.nih.gov/pubmed/34564675
https://www.proquest.com/docview/2576502055
https://search.proquest.com/docview/2576907759
https://pubmed.ncbi.nlm.nih.gov/PMC8471557
https://doaj.org/article/afc6f9a7ac414c809cee02b1394deb17
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLa28cILAsYlMCojIXjKmosdJ49ttTEhtaqmTepb5NjOiNQ6U5Mgyr_gH3OOm1Yt4omXPORiWTnX7_jzMSGfwGKY4Sbyo7AMfFxa8yXjgR8WLNYFAOekxDrkdJbc3LNvC744IXy3F8aR9lVRXdrl6tJW3x238nGlhjue2HA-naBH5YDkT8kphN8DiO7cbxwjBtk2aIwB0g_b-mdlG3DWGbhmPBomxh4qCVILD2KRa9n_rzzzb7rkQfy5fk6e9YkjHW0n-IKcGPuSnI8sgObVhn6mjsrpauTn5PfMdK6C8QsCE53gzkTbt8dtaF3SkW0rf1y3yELvVvQOZ-5uFjWSCuncMbl-mOUGPl677S6GYsWWTuuuMXQ_vBuSgojlht6aplu2DYWhJP3aQfYq6bx6oHja2vIVub--upvc-P3ZC75iKWt9naQyLFRotNGxDhKZshKgB2NaBhpSCB0ykWEjl1ADxFRGg1M1kpcgaI0ni8evyZmtrXlLKORYseZCiExFrFQiS5mOUsgLpCiUTJhHvuykkD9uW2zkAE1QdPmx6DwyRiHt38LW2O5GvX7IewXJZamSMpNCKpiGSoMM0oAgKiDTZRoCk_DIxU7EeW-vTY6wi0PmzLlHPu4fg6Xh8om0Bn6ueyfDjoGZR95sNWI_k51GeUQc6crRVI-fgHK7bt69Mr_77y_fk6cREm1wqSy8IGftujMfIFNqiwHYx0IMyJPx1Wx-O3D1BrhOWTpwNvMH4SYc1g
link.rule.ids 230,314,727,780,784,864,885,2102,2221,12056,21388,24318,27924,27925,31719,31720,33744,33745,43310,43805,53791,53793,73745,74302
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED9B9wAvCBgf2QYYCcFTtHzY-XhC7bRRYK2qqZP2Fjm2Myp1yWgSRPkv-I-5c9NAEeLVcaxTznf-3fnyO4A3aDHcCBO4gV94Ll2tuZILz_VzHuocA-eooDzkZBqNL_mnK3HVJdzqrqxy6xOto9aVohz5MQFjgdhGiPe3X13qGkW3q10LjbuwR8zpYgB7o9Pp7KLPsnhhSAHJhq0xxPj-uKm-L8oaPXeKftrfOY0saf-_kObfBZN_nEBnD-FBBx3ZcKPrR3DHlI9hf1hi2HyzZm-ZLea0WfJ9-Dk1rc1h_MCjiZ3Qv4llR5Bbs6pgw7JZuKOqoTr09obNSVw7mFdUVshmtpbrm1mu8eWV_eHFMMrZsknV1ob1y9slGSpZrtmFqdtlUzNcSrIPLeJXyWaLa0b91pZP4PLsdH4ydrvuC67iCW9cHSXSz5VvtNGh9iKZ8AKDD8619DSCCO3zOCUqF19jkKmMRrdqpChQ1Zp6i4dPYVBWpXkODFFWqEUcx6kKeKHiNOE6SBAZyDhXMuIOvNtqIbvdkGxkGJyQvrJdfTkwIiX1s4gc2w5Uq-uss7VMFioqUhlLhWKoxEsRCHhBjliXazyaYgeOtirOOouts9_7y4HX_WO0NbpAkaXBj2vnpMQZmDrwbLMjeklC4uXB6MuBeGev7Ii6-6RcfLF83gQQhIgP_i_WK7g3nk_Os_OP08-HcD-g2hq6HfOPYNCsWvMCwVGTv-ws4BfV2RPC
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZgKyEuCCiPQAEjIThFm4cdJye0W7qUR1erqpV6ixzbKSttk7JJEMu_4B8z4_UGghDXPKxRxjPzzfjLDCGvwGKY4Sbyo7AMfDxa8yXjgR8WLNYFJM5JiXXIk3lyfM4-XvALx39qHK1y5xOto9a1whr5GIExB2zD-bh0tIjFu9nb668-TpDCk1Y3TuMm2YOoGEQjsjc9mi9O-4pLEMeYnGw7N8aQ64_b-vuyasCLZ-Czw0Fksg38_4U6_yZP_hGNZnfJHQcj6WSr93vkhqnuk_1JBSn01Ya-ppbYaSvm--Tn3HS2nvEDwhQ9xP8UK9cst6F1SSdVu_SndYuc9O6KnqG49mJRI8WQLiyv65tZbeDltf35xVCs39KTumsM7Ze3S1JQuNzQU9N0q7ahsJSk7zvAspIulpcUZ6-tHpDz2dHZ4bHvJjH4iqWs9XWSyrBQodFGxzpIZMpKSEQY0zLQACh0yESGbV1CDQmnMhpcrJG8BLVrnDMePySjqq7MY0IBccWaCyEyFbFSiSxlOkoBJUhRKJkwj7zZaSG_3jbcyCFRQX3lQ315ZIpK6p_CRtn2Qr2-zJ3d5bJUSZlJIRWIodIgA1AQRAXgXqYhTAmPHOxUnDvrbfLfe80jL_vbYHd4mCIrAx_XPpNh_8DMI4-2O6KXJMYePZCJeUQM9spA1OGdavnF9vZGsMC5ePJ_sV6QW7D5888f5p-ektsR0mzwoCw8IKN23ZlngJPa4rkzgF9hpxfv
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neutralizing+Concentrations+of+Anti-Botulinum+Toxin+Antibodies+Positively+Correlate+with+Mouse+Neutralization+Assay+Results+in+a+Guinea+Pig+Model&rft.jtitle=Toxins&rft.au=Tomic%2C+Milan+T.&rft.au=Farr-Jones%2C+Shauna&rft.au=Syar%2C+Emily+S.&rft.au=Niemuth%2C+Nancy&rft.date=2021-09-21&rft.pub=MDPI&rft.eissn=2072-6651&rft.volume=13&rft.issue=9&rft_id=info:doi/10.3390%2Ftoxins13090671&rft_id=info%3Apmid%2F34564675&rft.externalDBID=PMC8471557
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2072-6651&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2072-6651&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2072-6651&client=summon